(Q37683496)

English

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment

scientific article published on 31 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Rift Valley fever phlebovirus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rift Valley fever

1 reference

based on heuristic

inferred from title

Rift Valley fever virus

object named as

Rift Valley fever virus

1 reference

based on heuristic

inferred from title

Arnaud Van Wettere

6

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

author name string

Dionna Scharton

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Kevin W Bailey

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Zachary Vest

3

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Jonna B Westover

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Yohichi Kumaki

5

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Yousuke Furuta

7

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Brian B Gowen

8

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 January 2014

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Antiviral Research

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

104

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

84-92

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

The pathogenesis of Rift Valley fever

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Molecular strategies to inhibit the replication of RNA viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Treatment of Crimean-Congo hemorrhagic fever

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Dose translation from animal to human studies revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Mechanisms of action of ribavirin against distinct viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Hemorrhagic fever viruses as biological weapons: medical and public health management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Ribavirin--current status of a broad spectrum antiviral agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

Lassa fever. Effective therapy with ribavirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 August 2017

The pathogenesis of Rift Valley fever virus in the mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

14 September 2017

Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

14 September 2017

Mechanism of action of T-705 against influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

28 September 2017

Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

28 September 2017

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

28 September 2017

Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

28 September 2017

Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 June 2018

Punta Toro virus infection of C57BL/6J mice: a model for phlebovirus-induced disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975078

23 June 2018

Identifiers

10.1016/J.ANTIVIRAL.2014.01.016

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37683496&oldid=2154318765"